Solventum Corp
SOLVNYSEHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|
| Revenue | $8.32B | $8.25B | $8.20B | $8.13B |
| Operating income | $2.18B | $1.04B | $1.69B | $1.69B |
| Net income | $1.56B | $479.0M | $1.35B | $1.34B |
| Total assets | $14.29B | $14.46B | $13.94B | — |
| Total liabilities | $9.24B | $11.50B | $2.28B | — |
| Equity | $5.05B | $2.96B | $11.67B | $11.74B |
| EPS (diluted) | $8.88 | $2.76 | $7.79 | $7.78 |
| Shares out. | 173.0M | 0 | 0 | 172.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 26.2%
- Net margin
- 18.7%
- Return on equity
- 30.8%
- Return on assets
- 10.9%
- Return on capital (ROCE)
- 19.5%
- Liabilities / assets
- 64.7%
- Debt / equity
- 1.83×
- Book value / share
- $29.19
- Revenue growth (YoY)
- 0.9%
- Net income growth (YoY)
- 224.8%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 2.34grey zone
- Accruals / assets
- 8.3%moderate
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 4 good- Altman Z″ in the grey zone
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
FDA-approved drugs
openFDA · most recent- SOLUPREP SAug 8, 2018
- DURAPREPSep 29, 2006
- AVAGARDJun 7, 2001
- PERIDEXAug 13, 1986
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Capital Management LlcPassive (13G)Apr 30, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Independent Franchise Partners LlpPassive (13G)Jan 27, 2026
- 3m CoPassive (13G)Aug 18, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 7.9M | 4.1 | +21.7% |
| Apr 30, 2026 | 6.5M | 6.4 | +1.6% |
| Apr 15, 2026 | 6.4M | 5.0 | +18.6% |
| Mar 31, 2026 | 5.4M | 3.5 | +35.7% |
| Mar 13, 2026 | 4.0M | 2.9 | +13.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeMay 27, 2026
- Shareholder voteMay 20, 2026
- Results of operationsMay 5, 2026
- Director / officer changeMar 24, 2026
- Results of operationsFeb 26, 2026
- Regulation FD disclosureDec 16, 2025
- Results of operationsNov 6, 2025
- Director / officer changeOct 21, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Corporate family
Spun off from 3M CompanyMMM · Mar 26, 2024
From the spin-off filings we track. Follow a company to walk its own history.